Back to top

Swedish Orphan price target raised to SEK 530 from SEK 470 at Barclays

Barclays raised the firm’s price target on Swedish Orphan Biovitrum (BIOVF) to SEK 530 from SEK 470 and keeps an Overweight rating on the shares. P...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Swedish Orphan Biovitrum (BIOVF)